Table 1 Demographic and clinical characteristics of European American Diabetes Heart Study (DHS) participants
Mean ± SD or % | Median (range) | |
|---|---|---|
Demographic information | ||
Age (years) | 62.0 ± 9.3 | 62.6 (35–86) |
Gender (% female) | 53.3% | |
Type 2 diabetes affected (%) | 83.7% | |
Diabetes duration (years) | 10.4 ± 7.2 | 8 (0–46) |
% smoking (current or past) | 58.7% | |
Self-reported history of prior CVD (%) | 39.0% | |
Deceased (%) | 20.9% | |
Deceased from CVD (%) | 9.0% | |
Body composition | ||
Height (cm) | 168.6 ± 9.7 | 168.4 (122.8–202.0) |
Weight (kg) | 90.6 ± 20.2 | 88.3 (40.0–209.2) |
BMI (kg/m2) | 31.8 ± 6.5 | 30.8 (16.6–58.0) |
Medications | ||
Lipid lowering (%) | 44.7% | |
ACR/ARB (%) | 44.7% | |
Blood pressure | ||
Systolic BP (mmHg) | 139 ± 19 | 138 (70–260) |
Diastolic BP (mmHg) | 73 ± 10 | 73 (37–106) |
Hypertension (%) | 84.9% | |
Blood biochemistry | ||
Glucose (mg/dL) | 139.3 ± 55.3 | 126 (16–463) |
Hemoglobin A1C (%) | 7.3 ± 1.7 | 6.9 (3.5–18.3) |
Total cholesterol (mg/ dL) | 186.8 ± 42.3 | 183 (65–427) |
HDL-cholesterol (mg/dL) | 43.1 ± 12.4 | 41 (8–104) |
LDL-cholesterol (mg/dL) | 105.2 ± 32.6 | 103 (12–236) |
Triglycerides (mg/dL) | 200.9 ± 131.6 | 172 (30–1310) |
Albumin (g/dL) | 4.2 ± 0.3 | 4.2 (3.2–5.3) |
Kidney function | ||
Serum creatinine (mg/dL) | 1.08 ± 0.25 | 1.10 (0.40–1.75) |
Estimate glomerular filtration rate (mL/min/1.73m2) | 67.1 ± 20.2 | 64.3 (20.0–179.9) |
Urine albumin/creatinine ratio (mg/g) | 91.1 ± 319.9 | 12.4 (0.5–4165.0) |
Vascular imaging | ||
Coronary artery calcified plaque (Agatston units) | 1657 ± 3148 | 330 (0–50415) |